Indian Court Lifts Curbs On Herceptin Biosimilars; Roche Sticks To Guns

An Indian court has, in a seesaw turn, lifted certain restrictions pertaining to partners Biocon and Mylan’s biosimilar versions of Roche’s Herceptin (trastuzumab). Roche, though, doesn’t seem keen to back off just yet and continues to rake up issues around data requirements for biosimilars.